The mechanism by which muscle or any other molecular motor converts chemical energy (ATP) into mechanical work, force, and shortening (chemomechanical transduction) will be studied. Current theories of this process are based on a four step reaction mechanism in which ATP binds to and dissociates actomyosin, followed by strong binding of the myosin products complex to actin and the associated sequential release of Pi and ADP. The release of products powers the rotation of the myosin head, the power stroke, and produces the motive force and sliding of the thick and thin filaments. The rate of ATP hydrolysis, the force produced, and the velocity of shortening are all dependent on the rate constants controlling the transition between different AM states and the rate constants themselves are a function of the strain on the crossbridge. Using transient kinetics in solutions of isolated proteins to study the rates of steps in dissociating or dissociated proteins, and glycerinated fibers to examine the rate constant for actomyosin transitions and ATP hydrolysis, and the recently developed in vitro motility assays, we will test a number of these ideas. A major challenge to conventional wisdom are experiments indicating that the power stroke is much larger than possible by the rotating crossbridge concept. The power stroke size will be estimated by measuring the time course of ATP hydrolysis, shortening, and stiffness in single shortening glycerinated muscle fibers. In comparative studies (using motility assays) the power stroke size produced by myosins from skeletal and smooth muscles and platelets will be estimated. Second, using ATP analogues to produce contractions in which force, rate of force development, Pi transients, and velocity of shortening are different, we will determine to what extend these differences are explicable by measured changes in the rate constants of the actomyosin reaction mechanism. These same studies, when applied to motility assays, will allow determination of the extent to which the motility assay is a paradigm of muscle contraction. Attempts will be made to develop a technique by which the number of strongly attached crossbridges to a length of moving actin filament can be estimated. If successful this would allow evaluation as to what extent stiffness is an adequate measure of the number of attached crossbridges. Finally an attempt will be made to load crossbridges and examine their velocity-pCa relationship.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR030988-14
Application #
2078740
Study Section
Physiology Study Section (PHY)
Project Start
1982-05-01
Project End
1997-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Physiology
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Siththanandan, V B; Tobacman, L S; Van Gorder, N et al. (2009) Mechanical and kinetic effects of shortened tropomyosin reconstituted into myofibrils. Pflugers Arch 458:761-76
Sumandea, Marius P; Vahebi, Susan; Sumandea, C Amelia et al. (2009) Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function. Biochemistry 48:7722-31
Homsher, E; Nili, M; Chen, I Y et al. (2003) Regulatory proteins alter nucleotide binding to acto-myosin of sliding filaments in motility assays. Biophys J 85:1046-52
Pavlov, Dmitry; Gerson, Jack H; Yu, Tianwei et al. (2003) The regulation of subtilisin-cleaved actin by tropomyosin/troponin. J Biol Chem 278:5517-22
Piroddi, N; Tesi, C; Pellegrino, M A et al. (2003) Contractile effects of the exchange of cardiac troponin for fast skeletal troponin in rabbit psoas single myofibrils. J Physiol 552:917-31
Burkart, Eileen M; Sumandea, Marius P; Kobayashi, Tomoyoshi et al. (2003) Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 278:11265-72
Tobacman, Larry S; Nihli, Mahta; Butters, Carol et al. (2002) The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem 277:27636-42
Karibe, A; Tobacman, L S; Strand, J et al. (2001) Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103:65-71
Strand, J; Nili, M; Homsher, E et al. (2001) Modulation of myosin function by isoform-specific properties of Saccharomyces cerevisiae and muscle tropomyosins. J Biol Chem 276:34832-9
Gordon, A M; Regnier, M; Homsher, E (2001) Skeletal and cardiac muscle contractile activation: tropomyosin ""rocks and rolls"". News Physiol Sci 16:49-55

Showing the most recent 10 out of 31 publications